These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3543501)

  • 41. Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis.
    Schmidt WN; Katzenellenbogen BS
    Mol Cell Endocrinol; 1979 Aug; 15(2):91-108. PubMed ID: 499651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptors and biological responses to ovarian steroid hormones in the fetal and perinatal periods.
    Pasqualini JR; Sumida C; Gulino A
    Int Rev Physiol; 1983; 27():225-73. PubMed ID: 6343290
    [No Abstract]   [Full Text] [Related]  

  • 43. Steroid antagonists as nuclear receptor blockers.
    Wakeling AE
    Cancer Surv; 1992; 14():71-85. PubMed ID: 1423332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiestrogenic effect of gestrinone as an inhibitor of [3H]-estradiol binding to nuclear type II sites.
    Ohno Y; Kitagawa I; Tamura H; Hosoda S; Yamashita S; Honjo H; Okada H
    Gynecol Obstet Invest; 1991; 31(2):97-101. PubMed ID: 2037266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Steroid hormone target sites in the brain: the differential distribution of estrogin, progestin, androgen and glucocorticosteroid.
    Stumpf WE; Sar M
    J Steroid Biochem; 1976; 7(11-12):1163-70. PubMed ID: 1025363
    [No Abstract]   [Full Text] [Related]  

  • 46. Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion.
    Shapiro E; Lippman ME
    J Steroid Biochem; 1985 Jan; 22(1):15-20. PubMed ID: 3871880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay.
    Gaido KW; Leonard LS; Lovell S; Gould JC; Babaï D; Portier CJ; McDonnell DP
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):205-12. PubMed ID: 9073609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human breast cancer: androgen action mediated by estrogen receptor.
    Zava DT; McGuire WL
    Science; 1978 Feb; 199(4330):787-8. PubMed ID: 622569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid analogs inhibit hormone binding by an extract from Nippostrongylus brasiliensis (Nematoda).
    Majundar TK; Parish EJ; Bone LW
    Comp Biochem Physiol B; 1987; 88(1):81-4. PubMed ID: 3677617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antiprogestins].
    Göretzlehner G; Köhler G
    Zentralbl Gynakol; 1988; 110(12):766-71. PubMed ID: 3063028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol.
    Tamaya T; Fujimoto J; Watanabe Y; Arahori K; Okada H
    Acta Obstet Gynecol Scand; 1986; 65(5):439-41. PubMed ID: 3490730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Towards the mapping of the progesterone and androgen receptors.
    Ojasoo T; Delettré J; Mornon JP; Turpin-VanDycke C; Raynaud JP
    J Steroid Biochem; 1987; 27(1-3):255-69. PubMed ID: 3695484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hormone dependence and the basis of hormone therapy in breast cancer].
    Martin PM
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):183-99. PubMed ID: 209076
    [No Abstract]   [Full Text] [Related]  

  • 54. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biology and mode of action of pure antioestrogens.
    Wakeling AE; Bowler J
    J Steroid Biochem; 1988; 30(1-6):141-7. PubMed ID: 3386242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparison of progestin and androgen receptor binding using the CoMFA technique.
    Loughney DA; Schwender CF
    J Comput Aided Mol Des; 1992 Dec; 6(6):569-81. PubMed ID: 1291626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation, transformation, and subunit structure of steroid hormone receptors.
    Grody WW; Schrader WT; O'Malley BW
    Endocr Rev; 1982; 3(2):141-63. PubMed ID: 7044769
    [No Abstract]   [Full Text] [Related]  

  • 59. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH).
    Asselin J; Mélançon R; Gourdeau Y; Labrie F; Bonne C; Raynaud JP
    J Steroid Biochem; 1979 May; 10(5):483-6. PubMed ID: 88546
    [No Abstract]   [Full Text] [Related]  

  • 60. The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro.
    Rose GL; Dowsett M; Mudge JE; White JO; Jeffcoate SL
    Fertil Steril; 1988 Feb; 49(2):224-8. PubMed ID: 3338580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.